March 1, 2020 - Volume 34 - Issue 3 : AIDS

Secondary Logo

Journal Logo

March 1, 2020 - Volume 34 - Issue 3
pp: 335-491

Presence of Epstein–Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation

Lupia, Tommaso; Milia, Maria Grazia; Atzori, Cristiana; More

AIDS. 34(3):373-380, March 1, 2020.

Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery

Tenore, Simone de Barros; Avelino-Silva, Vivian Iida; Costa, Priscilla Ramos; More

AIDS. 34(3):381-389, March 1, 2020.

Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa

Puryear, Sarah B.; Balzer, Laura B.; Ayieko, James; More

AIDS. 34(3):405-413, March 1, 2020.

Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infection

Kallianpur, Kalpana J.; Jahanshad, Neda; Sailasuta, Napapon; More

AIDS. 34(3):415-426, March 1, 2020.

Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?

Rial-Crestelo, David; Sepúlveda, María Antonia; González-Gasca, Francisco Javier; More

AIDS. 34(3):427-432, March 1, 2020.

The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities

Krebs, Emanuel; Zang, Xiao; Enns, Benjamin; More

AIDS. 34(3):447-458, March 1, 2020.

Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV

Safarpour, Hanie; Cevik, Muge; Zarean, Mehdi; More

AIDS. 34(3):469-474, March 1, 2020.

Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia

Hoffman, Risa M.; Balakasi, Kelvin; Bardon, Ashley R.; More

AIDS. 34(3):475-479, March 1, 2020.